Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.4950 (-3.72%) ($10.4950 - $10.4950) on Fri. Dec. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.08% (three month average) | RSI | 63 | Latest Price | $10.4950(-3.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.5% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ICLN(69%) IFRA(67%) IWN(66%) ACES(63%) IPO(63%) | Factors Impacting EDIT price | EDIT will decline at least -2.54% in a week (0% probabilities). TBT(-27%) VXX(-24%) BNDX(-21%) VIXM(-19%) EDOC(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.54% (StdDev 5.08%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.9(-3.72%) | 10 Day Moving Average | $10.78(-2.64%) | 20 Day Moving Average | $10.11(3.81%) | To recent high | -5.3% | To recent low | 67.7% | Market Cap | $652m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |